(A) Reduced attachment of A549 cells with stable expression of muskelin-shRNA clone 2 (cl2) and clone 3 (cl3) cells to the TSP-1 C-terminal protein T3GCT. Adhesion assays were performed for 1 h under serum-free conditions as previously described (). (B and C) Cell perimeter measurements for control and muskelin-depleted A549 (B) or C2C12 (C) cells adherent on 50 nM FN for 1 h. (B) A549 lines were also compared after 48 h expression of GFP or GFP-MK. Only GFP-MK restored normal morphology. In each graph, each column represents the mean of three independent experiments. Error bars indicate SEM. *, P ≤ 0.0001. (D) Representative F-actin organization in control and muskelin-depleted C2C12 cells under the same experimental conditions as in C. Ba...
<p>(A) HeLa cells transfected with control siRNA or with BAG3-specific siRNA (siBAG3_1) were synchro...
<p>(<b><i>A-C)</i></b> RPE cells were transfected with siRNA targeting AMPK α1/2 or non-targeting (N...
(A) HeLa cells were treated with control siRNAs or independent siRNAs targeting mDia1 and infected w...
Molecular mass markers are shown in kilodaltons. (C–F) Merged confocal images showing localization o...
(B) MDCK cells transfected with GFP-TM5b or GFP (green) were treated without (top) or with (bottom) ...
<p><b>(A)</b> Live wildtype MCF10A cells expressing mCherry-PA-Rac1 and GFP-α-catenin were imaged ov...
<p>Mtss1 siRNA disrupts cell-cell junctions in confluent Scc9 cells. (A) Scc9 cells were treated wit...
Pretreatment with H89 was also performed using the cells transfected with TM5b siRNA (D) or the cont...
Bar, 10 μm. (B) Quantification of the cellular localizations of GFP-MK or cyclin B1 in cells treated...
<p>A) MDA-MB-231 cells were plated on matrigel-coated coverslips for 20 hours in FCS containing medi...
<p>A. Beas2B cells were transfected with either control siRNA or siRNAs specific to G<sub>α16</sub> ...
(a) Western blots show Huntingtin signal is reduced in Control 1 fibroblasts treated with siRNA targ...
<p>(<b>A</b>) Immunoblot showing that ARHGAP22 is depleted after 48 h of siRNA treatment of C2C12 ce...
<p>MCs were analyzed 48 hours after transfection with siRNA against Notch2 or control siRNA. (A) Rel...
(C) MDCK cells were transfected with DsRed-AQP2 (red) and GFP-TM5b (green) and stimulated with forsk...
<p>(A) HeLa cells transfected with control siRNA or with BAG3-specific siRNA (siBAG3_1) were synchro...
<p>(<b><i>A-C)</i></b> RPE cells were transfected with siRNA targeting AMPK α1/2 or non-targeting (N...
(A) HeLa cells were treated with control siRNAs or independent siRNAs targeting mDia1 and infected w...
Molecular mass markers are shown in kilodaltons. (C–F) Merged confocal images showing localization o...
(B) MDCK cells transfected with GFP-TM5b or GFP (green) were treated without (top) or with (bottom) ...
<p><b>(A)</b> Live wildtype MCF10A cells expressing mCherry-PA-Rac1 and GFP-α-catenin were imaged ov...
<p>Mtss1 siRNA disrupts cell-cell junctions in confluent Scc9 cells. (A) Scc9 cells were treated wit...
Pretreatment with H89 was also performed using the cells transfected with TM5b siRNA (D) or the cont...
Bar, 10 μm. (B) Quantification of the cellular localizations of GFP-MK or cyclin B1 in cells treated...
<p>A) MDA-MB-231 cells were plated on matrigel-coated coverslips for 20 hours in FCS containing medi...
<p>A. Beas2B cells were transfected with either control siRNA or siRNAs specific to G<sub>α16</sub> ...
(a) Western blots show Huntingtin signal is reduced in Control 1 fibroblasts treated with siRNA targ...
<p>(<b>A</b>) Immunoblot showing that ARHGAP22 is depleted after 48 h of siRNA treatment of C2C12 ce...
<p>MCs were analyzed 48 hours after transfection with siRNA against Notch2 or control siRNA. (A) Rel...
(C) MDCK cells were transfected with DsRed-AQP2 (red) and GFP-TM5b (green) and stimulated with forsk...
<p>(A) HeLa cells transfected with control siRNA or with BAG3-specific siRNA (siBAG3_1) were synchro...
<p>(<b><i>A-C)</i></b> RPE cells were transfected with siRNA targeting AMPK α1/2 or non-targeting (N...
(A) HeLa cells were treated with control siRNAs or independent siRNAs targeting mDia1 and infected w...